Apronax | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Apronax
Canada

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Contact Supplier

Topscience Biotech specializes in R&D, production, sales of Sodium Hyaluronate, focusing on Cosmetics, Medical, Pharmaceutical Grade HA

Contact Supplier

Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

China

Contact Supplier

Apronax

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

78 API Suppliers, 23 USDMF, 12 CEP/COS, 1 JDMF, 3 EU WC, 36 KDMF, 12 NDC API, 1 VMF, 19 Listed Suppliers, $ API Reference Price

78 API Suppliers
23 USDMF
12 CEP/COS
1 JDMF
3 EU WC
36 KDMF
12 NDC API
1 VMF
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

339 FDF Dossiers, 115 FDA Orange Book, 96 Europe, 25 Canada, 23 Australia, 25 South Africa, 55 Listed Dossiers

339 FDF Dossiers
115 FDA Orange Book
96 Europe
25 Canada
23 Australia
25 South Africa
55 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG, TABLET;ORAL - 375MG, TABLET;ORAL - 500MG, SUSPENSION;ORAL - 25MG/ML, TABLET, DELAYED RELEASE;ORAL - 375MG, TABLET, DELAYED RELEASE;ORAL - 500MG, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG
TABLET;ORAL - 375MG
TABLET;ORAL - 500MG
SUSPENSION;ORAL - 25MG/ML
TABLET, DELAYED RELEASE;ORAL - 375MG
TABLET, DELAYED RELEASE;ORAL - 500MG
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

7 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 6 DKSH, 6 Faran Shimi Pharmaceutical, 11 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 33 BASF, 1 Clariant, 14 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 12 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Coating Systems & Additives, 71 Fillers, Diluents & Binders, 41 Controlled & Modified Release, 39 Disintegrants & Superdisintegrants, 35 Solubilizers, 31 Thickeners and Stabilizers, 29 Direct Compression, 27 Granulation, 24 Film Formers & Plasticizers, 20 Taste Masking, 17 Lubricants & Glidants, 17 Co-Processed Excipients, 16 Topical, 15 Parenteral, 11 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 7 Rheology Modifiers, 6 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

72 Coating Systems & Additives
71 Fillers, Diluents & Binders
41 Controlled & Modified Release
39 Disintegrants & Superdisintegrants
35 Solubilizers
31 Thickeners and Stabilizers
29 Direct Compression
27 Granulation
24 Film Formers & Plasticizers
20 Taste Masking
17 Lubricants & Glidants
17 Co-Processed Excipients
16 Topical
15 Parenteral
11 Chewable & Orodispersible Aids
8 Emulsifying Agents
7 Rheology Modifiers
6 API Stability Enhancers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

35 News #PharmaBuzz

35 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 83 Regulatory FDF Prices, 1 Annual Reports

1 US Medicaid Prescriptions
83 Regulatory FDF Prices
1 Annual Reports

MARKET PLACE

34 APIs, 3 FDF Dossiers

34 APIs
3 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 9 Others

3 EDQM
9 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 35 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

25 All

01 2Orion Corporation

02 6APOTEX INC

03 2ATNAHS PHARMA UK LIMITED

04 2MYLAN PHARMACEUTICALS ULC

05 1Medexus Pharmaceuticals

06 1PRO DOC LIMITEE

07 3Pharmascience Inc.

08 6TEVA CANADA LIMITED

09 2XEDITON PHARMACEUTICALS INC

filter Active Ingredients Reset all filters

25 All

01 20NAPROXEN

02 5Naproxen

filter Dosage Form Reset all filters

25 All

01 2ORAL SUSPENSION

02 1SUPPOSITORY

03 1SUSPENSION

04 6TABLET

05 10TABLET (ENTERIC-COATED)

06 1TABLET (EXTENDED-RELEASE)

07 4TABLET (IMMEDIATE AND DELAYED-RELEASE)

filter Brand Name Reset all filters

25 All

01 3APO-NAPROXEN

02 2APO-NAPROXEN EC

03 1APO-NAPROXEN EC TABLETS

04 2MYLAN-NAPROXEN/ESOMEPRAZOLE MR

05 2NAPROSYN

06 1PEDIAPHARM NAPROXEN SUSPENSION

07 1PMS-NAPROXEN

08 2PMS-NAPROXEN EC

09 1PRO-NAPROXEN EC

10 3TEVA-NAPROXEN

11 3TEVA-NAPROXEN EC

12 2VIMOVO

13 2Blank

List of Suppliers

Product Main Page

01

Orion Corporation

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Generic

Registration Country : Canada

Brand Name :

Dosage Form : ORAL SUSPENSION

Dosage Strength : 100ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

Fermion Orion Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Orion Corporation

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Generic

Registration Country : Canada

Brand Name :

Dosage Form : ORAL SUSPENSION

Dosage Strength : 200ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

Fermion Orion Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ATNAHS PHARMA UK LIMITED

IMCAS Asia

Not Confirmed

ATNAHS PHARMA UK LIMITED

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : NAPROSYN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 750MG

Packaging : 100

Approval Date :

Application Number : 2162466

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ATNAHS PHARMA UK LIMITED

IMCAS Asia

Not Confirmed

ATNAHS PHARMA UK LIMITED

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : NAPROSYN

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 500MG

Packaging : 100/500

Approval Date :

Application Number : 2162423

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Medexus Pharmaceuticals

IMCAS Asia

Not Confirmed

Medexus Pharmaceuticals

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PEDIAPHARM NAPROXEN SUSPENSION

Dosage Form : SUSPENSION

Dosage Strength : 25MG/ML

Packaging : 474ML

Approval Date :

Application Number : 2162431

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pharmascience Inc.

IMCAS Asia

Not Confirmed

Pharmascience Inc.

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-NAPROXEN

Dosage Form : SUPPOSITORY

Dosage Strength : 500MG

Packaging : 42673

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

07

Pharmascience Inc.

IMCAS Asia

Not Confirmed

Pharmascience Inc.

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-NAPROXEN EC

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 500MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

08

Pharmascience Inc.

IMCAS Asia

Not Confirmed

Pharmascience Inc.

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-NAPROXEN EC

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 375MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

09

TEVA CANADA LIMITED

IMCAS Asia

Not Confirmed

TEVA CANADA LIMITED

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TEVA-NAPROXEN

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging : 100/500

Approval Date :

Application Number : 589861

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

TEVA CANADA LIMITED

IMCAS Asia

Not Confirmed

TEVA CANADA LIMITED

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TEVA-NAPROXEN

Dosage Form : TABLET

Dosage Strength : 375MG

Packaging : 100/500

Approval Date :

Application Number : 627097

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!